| Lupin to mkt ItalFarmaco's cardiac drug |
| Our Web Bureau / Mumbai May 15, 2006 |
| Lupin has signed an in-licensing agreement with ItalFarmaco, a leading Italian pharmaceutical company, to market their cardiovascular product, Enoxaparin Sodium Injection, in pre-filled syringes under the brand name Lupenox in the Indian market. This was announced in a release issued by Lupin to the BSE today. "Lupin has always made quality products affordable to Indian patients. Our tie-up with ItalFarmaco is yet another effort in this direction. We believe Lupenox, being a superior quality product sourced from ItalFarmaco |
